Ingredient news
EFSA Novel-Food Workflow Reminds Applicants to Control Dossier Identity
By Nutranexa News |
EFSA's application overview describes pre-submission, online submission, suitability checks, scientific assessment, and post-adoption responsibility.
What Was Reported
EFSA's novel-food application procedure describes a four-phase process: preparing an application, submitting it through the European system, suitability checking and validation, scientific assessment, and post-adoption publication and possible authorisation by risk managers.
EFSA's process also explains that applications need information on composition, nutrition, toxicology, allergenicity, production process, proposed uses, and use levels. A dossier cannot be made reliable by adding a generic supplier certificate if the material identity changes.
Ingredient Buyer Context
PS buyers reviewing an EU novel-food question should first confirm whether the exact source, process, and intended use fall within the applicable route. Preserve the identity statement and document revision across supplier, importer, regulatory consultant, and finished-product files.
The source concerns the named study, company, agency, or market development. It should not be expanded into a medical treatment claim, a universal ingredient result, or a guarantee about a supplier or finished product.
Nutranexa Takeaway
The workflow is not a statement that a Nutranexa PS product requires or has completed a novel-food application. Confirm the route for the exact product and market.
For a product-specific discussion, provide the target market, application, source preference, PS grade, annual quantity, packaging, and required documents. Nutranexa can then discuss the relevant product and quality evidence without assuming facts that are not in the current controlled file.